Energy Transfer and Sunoco Donate More Than $2 Million To Support Research at MD Anderson

Senior leaders from Energy Transfer joined MD Anderson Children’s Cancer Hospital faculty and staff to present a fundraising check for more than $2 million. Photo courtesy of Energy Transfer.

Leaders from The University of Texas MD Anderson Cancer Center were presented with more than $2 million from Energy Transfer and Sunoco. The funds, which will support pediatric cancer research at MD Anderson Children’s Cancer Hospital, were raised through the companies’ annual workplace giving campaign.

“We are grateful, year after year, for the unmatched generosity of Energy Transfer and Sunoco,” said Richard Gorlick, M.D., division head and chair of Pediatrics at MD Anderson. “Because of their commitment to our mission to end cancer, patients now and in the future will have access to better, more effective treatments through a new and improved standard of care.”

Since 2014, Energy Transfer and Sunoco employees have led a fundraising effort that has donated more than $15 million to MD Anderson. The annual campaign includes contributions from corporate funds and $1 million from the Energy Transfer/Sunoco Foundation. CAL's Convenience, an independent agent operator of more than 200 Stripes stores at Sunoco gas stations, contributed $65,000 to the effort this year. Every dollar raised will go directly toward MD Anderson’s innovative and lifesaving cancer research and patient programs.

“We are always inspired by the incredible researchers, doctors and nurses within the MD Anderson family,” said Chris Curia, Energy Transfer executive vice president and chief human resources officer. “Their mission, research and treatment efforts are renowned and have had major impacts on millions of patients and their families around the world. It is truly an honor for us to raise money every year to help them further their mission.”

Over the years, funds from Energy Transfer have gone to support numerous research projects, including menin inhibitor research, which is particularly impactful for pediatric patients facing leukemia and other blood diseases.

“Through our research with the menin inhibitor, we are identifying combinations to enhance efficacy and potentially cure more children,” said Branko Cuglievan, M.D., assistant professor of Pediatrics Patient Care at MD Anderson. “With support from Energy Transfer, we are bringing hope to our patients and their families.”